University Schleswig-Holstein
Lübeck, 23538, Germany
NCT Number: NCT04489914
Percutaneous catheter-assisted valve replacement in aortic position (TAVI) for patients with high perioperative risk has become a standard method in recent years. In addition to the detection of bleeding and cardiac rhythm complications, follow-up care is mainly focused on the monitoring of respiratory parameters after an operation under intubation anesthesia or deep analgosedation. In addition to normal oxygen therapy, non-invasive ventilation and, in case of weaning failure, renewed tracheal intubation in the first 24 h after TAVI have been considered. High flow oxygen therapy (HFOT) now provides a good opportunity to treat patients with a warmed and humidified air-oxygen mixture and to independently control the oxygen content in the inhaled air and the flow in the pharyngeal area.
The aim of the Study is to investigate the Change in oxygenation after high-flow oxygen therapy as a measure of weaning success in postinterventional patients after TAVI.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lübeck, 23538, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
high-flow oxygen therapy after percutaneous transfemoral aortic valve replacement
Time frame: 24 hours
The Gradient of paO2/FiO2 will be determined after TAVI via blood gas analysis
Drägerwerk AG & Co. KGaA
Industry
Observational Study on the Application of High-Flow Therapy in the Postinterventional Follow-up Care of Patients With Percutaneous Interventional Aortic Valve Replacement
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06983938
Closure Technique, Transcatheter Aortic Valve Replacement
Plano, Texas, United States
View Trial DetailsNCT04870424
Atrial Fibrillation New Onset, Colchicine
Bern, Switzerland
View Trial DetailsNCT05881291
General Anesthesia, Hemodynamics
Hangzhou, Zhejiang, China
View Trial DetailsNCT04107038
Transcatheter Aortic Valve Replacement
Charleston, South Carolina, United States
View Trial Details